Scientists want Britain to back COVID patent waivers

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 61 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 66%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Scientists on Friday called on British Prime Minister Boris Johnson to support the waiver of intellectual property rights for COVID-19 vaccines, tests and treatments in the wake of the rapid spread of the Omicron coronavirus variant.In a letter, also addressed to the British health, trade, business and fo

Scientists on Friday called on British Prime Minister Boris Johnson to support the waiver of intellectual property rights for COVID-19 vaccines, tests and treatments in the wake of the rapid spread of the Omicron coronavirus variant.

In a letter, also addressed to the British health, trade, business and foreign ministers, the scientists asked Johnson to support the World Trade Organization's Trade-Related Aspects of Intellectual Property Rights agreement. British officials have been sceptical about the usefulness of the waivers, but said they were open to talks with the United States and other WTO members after pressure from charities and calls from developing nations to tackle vaccine inequity.

"The crisis posed by the Omicron variant is a stark warning of the dangers posed by global vaccine inequality," the letter signed by around 300 epidemiology, health and infectious diseases experts said.The experts also urged Britain to persuade pharmaceutical companies to share their technology and know-how with the World Health Organization to accelerate vaccine supply to low and middle-income countries and ward off further coronavirus variants.

Omicron, which was first identified in southern Africa and Hong Kong, is spreading far faster than previous variants of the coronavirus, and is not likely to help countries achieve so-called herd immunity against COVID-19, according to leading disease experts.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna starts trial testing Omicron-specific COVID-19 booster shotWASHINGTON: US biotech company Moderna announced on Wednesday (Jan 26) that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus. The trials will involve a total of 600 adults - half of whom have already received two doses of
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »